Most Americans aged 50 and older expressed interest in a vaccine that could reduce their risk of developing dementia if they are at high risk, according to a survey.
Nearly three-quarters of the survey respondents (72.1%) indicated they would likely or definitely receive such a vaccine, as reported by J. Felipe Montano-Campos, PhD, from the University of Southern California’s Schaeffer Center for Health Policy and Government Service in Los Angeles, along with his co-authors.
About one-fifth of respondents (20.8%) were uncertain, while 7.2% stated they likely or definitely would not receive the vaccine, as outlined in a research letter in JAMA Network Open.
Women exhibited more hesitation compared to men (23.0% vs 18.5%) and were less likely to affirmatively say they would get the vaccine (29.1% vs 38.5%). Among racial groups, Black adults showed the highest levels of hesitation, being nearly half as likely as white adults to express definite intent to get the vaccine (19.8% vs 35.8%).
“Older adults are highly interested in receiving a preventive dementia vaccine, while relatively few are opposed,” said Montano-Campos. “As vaccine options emerge, efforts may be needed to address hesitancy among some groups, including those at higher risk for dementia.”
Currently, no vaccine is approved specifically to prevent dementia, but several studies have suggested a connection between shingles vaccination and a lower risk of developing dementia in older adults. A
Fuente: https://www.medpagetoday.com/neurology/dementia/123120
Join the doctors who get the most relevant medical news, curated by specialty, every week — no spam, unsubscribe anytime.
